Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05619809 · ClinicalTrials.gov registry record · NA

Chronic Thermogenic Dietary Supplement Consumption

A NA study of Body Weight Changes and Metabolism Changes, sponsored by Texas Tech University.

Completed
Registry status
NA
Development phase
52
Enrollment target
1
Study location

NCT05619809 is a NA study of Body Weight Changes and Metabolism Changes that has completed, run by Texas Tech University. The registered enrollment target is 52 participants, below the 67-participant average among 11 other Body Weight Changes trials with a reported enrollment target (22% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05619809, a NA study of Body Weight Changes and Metabolism Changes, has completed, sponsored by Texas Tech University.

COMPLETED
Registry status
NA
Development phase
52 participants
Enrollment target
1
Study location

Study Summary

This study is a randomized, double-blind, placebo-controlled trial. Healthy, exercising adult males and females will be recruited for participation. After providing informed consent, each participant will be randomized to one of three groups: 1) OxyShred thermogenic fat burner; 2) Placebo (PL); and 3) Control. All participants will complete a baseline laboratory visit consisting of assessments of body composition, anthropometry, metabolism, hemodynamics, dietary intake, exercise habits, and subjective variables. Participants in the two intervention groups (i.e., OxyShred and PL) will then be given dietary supplements for daily consumption, including OxyShred/PL and protein powder. Participants in all groups will complete the 4-week study and follow their usual training and nutrition habits - besides increased protein intake in the OxyShred and PL groups - along with questionnaires to assess compliance with the study protocol and potential side effects of supplementation. Following this 4-week period, participants will complete a second laboratory visit, where all baseline assessments will be repeated. The effects of group (OxyShred, PL, and control) and time (baseline, 4 weeks) will be statistically examined using linear models, along with appropriate post-hoc tests.

Interventions

  • DIETARY_SUPPLEMENT Placebo supplement
  • DIETARY_SUPPLEMENT Protein supplement
  • DIETARY_SUPPLEMENT Thermogenic dietary supplement

Study Locations (1)

Texas

  • Department of Kinesiology & Sport Management - Lubbock

Trial Details

FieldValue
Enrollment Target 52 participants
Start Date 2023-01-17
Est. Completion 2023-05-15
Phase NA

Sponsor

Texas Tech University

69 total trials

What the Registry Record Tells You About NCT05619809

The ClinicalTrials.gov registry entry for NCT05619809 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 67-participant average among 11 other Body Weight Changes trials with a reported enrollment target (22% lower). The listed sponsor is Texas Tech University, which has 69 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Body Weight Changes appearing as the primary indexed condition, and to 3 interventions - of which Placebo supplement is the first listed.

NCT05619809 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05619809 about?

NCT05619809 is a clinical study titled "Chronic Thermogenic Dietary Supplement Consumption". This study is a randomized, double-blind, placebo-controlled trial. Healthy, exercising adult males and females will be recruited for participation. After providing informed consent, each participant will be randomized to one of three groups: 1) OxyShred thermogenic fat burner; 2) Placebo (PL); and ...

What is the current status of trial NCT05619809?

This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2023-01-17. Estimated completion is 2023-05-15.

What conditions does trial NCT05619809 study?

This clinical trial studies the following conditions: Body Weight Changes, Metabolism Changes, Body Composition Changes, Anthropometric Changes, Hemodynamic Changes.

What interventions are being tested in trial NCT05619809?

The interventions under investigation include: Placebo supplement (DIETARY_SUPPLEMENT), Protein supplement (DIETARY_SUPPLEMENT), Thermogenic dietary supplement (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05619809?

This trial is sponsored by Texas Tech University, which has 69 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05619809 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Body Weight Changes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.